Article, 2024

Flavonoids Biotransformation by Human Gut Bacterium Dorea sp. MRG-IFC3 Cell-Free Extract

Journal of Microbiology and Biotechnology, ISSN 1017-7825, 1738-8872, Volume 34, 6, Pages 1270-1275, 10.4014/jmb.2403.03058

Contributors

Mi H.T.N. [1] Kim H. [1] Lee J.S. Eser B.E. 0000-0002-8836-1251 [2] Han J. 0000-0002-5328-3927 [1]

Affiliations

  1. [1] Chung-Ang University
  2. [NORA names: South Korea; Asia, East; OECD];
  3. [2] Aarhus University
  4. [NORA names: AU Aarhus University; University; Denmark; Europe, EU; Nordic; OECD]

Abstract

Human gut bacterium Dorea sp. MRG-IFC3 is unique in that it is capable of metabolizing puerarin, an isoflavone C-glycoside, whereas it shows broad substrate glycosidase activity for the various flavonoid O-glycosides. To address the question on the substrate specificity, as well as biochemical characteristics, cell-free biotransformation of flavonoid glycosides was performed under various conditions. The results showed that there are two different enzyme systems responsible for the metabolism of flavonoid C-glycosides and O-glycosides in the MRG-IFC3 strain. The system responsible for the conversion of puerarin was inducible and comprised of two enzymes. One enzyme oxidizes puerarin to 3"-oxo-puerarin and the other enzyme converts 3"-oxo-puearin to daidzein. The second enzyme was only active toward 3"-oxo-puerarin. The activity of puerarin conversion to daidzein was enhanced in the presence of Mn2+ and NAD+. It was concluded that the puerarin C-deglycosylation by Dorea sp. MRG-IFC3 possibly adopts the same biochemical mechanism as the strain PUE, a species of Dorea longicatena.

Keywords

C-C bond cleavage, Dorea sp. MRG-IFC3, flavonoid glycoside, puerarin

Data Provider: Elsevier